Search
Patexia Research
Case number 2024-1405

Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc. > Documents

Date Field Doc. No.Description (Pages)
Apr 12, 2024 3 ORDER Appeal Nos. 2024-1402 and 2024-1405 are dismissed. Each party shall bear iits own costs.; issuing mandate. (Per Curiam). Service as of this date by the Clerk of Court. [996970] [24-1402, 24-1405] [NL] [Entered: 04/12/2024 10:27 AM] (2)
Jan 30, 2024 1 Appeal docketed. Received: 01/29/2024. [980275]Entry of Appearance is due on 02/13/2024. Certificate of Interest is due on 02/13/2024. Docketing Statement is due on 02/13/2024. Appellant's brief is due on 04/01/2024. [JSP] [Entered: 01/30/2024 10:27 AM] (93)
Jan 30, 2024 2 Note to File: The following cases are consolidated: 24-1402 Lead with 24-1405 Cross-Appeal. The parties must file all documents in the lead appeal only. [980279] [24-1402, 24-1405] [JSP] [Entered: 01/30/2024 10:37 AM] (0)
Menu